RNAi articles within British Journal of Cancer

Featured

• Article | 25 August 2023

  PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies

  • Vishnu Kumarasamy
  • , Zhe Gao
  •  & Erik S. Knudsen

• Genetics and Genomics
  10 December 2013 | Open Access

  An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

  • A Linton
  • , Y Y Cheng
  •  & G Reid

• Mini Review
  20 November 2012 | Open Access

  Functional genomic screening to enhance oncolytic virotherapy

  • D J Mahoney
  •  & D F Stojdl

• Translational Therapeutics
  17 August 2010 | Open Access

  Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells

  • A Strillacci
  • , C Griffoni
  •  & E Spisni

• Molecular Diagnostics
  16 February 2010 | Open Access

  NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation

  • T Hosono
  • , T Tanaka
  •  & T Kamitani

• Translational Therapeutics
  19 January 2010 | Open Access

  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity

  • H Jia
  • , L Cheng
  •  & I Zachary